A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder. - A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder.

Soiken Inc.0 sites120 target enrollmentAugust 31, 2019

Overview

No summary available.

Registry

who.int

Start Date

August 31, 2019

End Date

September 8, 2018

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\) Subject who has a mental disease such as depression, schizophrenia, epilepsy and bulimia nervosa. 2\) Subject who has allergic disease, cardiovascular, respiratory, thyroid gland malfunction, diabetes, heart disease, heart disease, gout or sleep disorder. 3\) Subject who takes regularly medicinal drugs or medicines having an effect on the weight. 4\) Subject who has the possibility of developing allergic symptoms by the test food (noni allergy). 5\) Subject who has a snacking habit that influence the evaluation of the effects of the test food. 6\) Female subject who is pregnant or may be pregnant during the study. 7\) Female subject who is in the lactation during the study. 8\) Subject who took blood samples of 200 ml or more within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood). 9\) Subject who participated in other clinical trials within the past 4 months or currently participating in other clinical trials or planning to participate in other clinical trials during the examination period. 10\) Subject deemed unsuitable by the investigator.